Lido Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,000
Closed -$265K 1998
2025
Q4
$265K Hold
4,000
﹤0.01% 1629
2025
Q3
$269K Hold
4,000
﹤0.01% 1543
2025
Q2
$349K Hold
4,000
﹤0.01% 1268
2025
Q1
$273K Hold
4,000
﹤0.01% 1250
2024
Q4
$311K Hold
4,000
﹤0.01% 1198
2024
Q3
$268K Buy
+4,000
New +$328K ﹤0.01% 1206

Other funds holding DXCM

Lido Advisors's DXCM Position: Q1 2026 in Review

Lido Advisors increased its DexCom (DXCM) stake by 44% in Q1 2026, buying an estimated $705K and bringing the position to 33,324 shares worth $2.09M. The position accounts for 0.01% of the portfolio, ranked #691.

Lido Advisors first reported a position in DXCM in Q4 2018 and has held it in 28 quarters since. The position peaked at $8.49M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Lido Advisors held 33,324 shares of DexCom worth $2.09M as of Q1 2026.
  • Lido Advisors bought 10,125 DexCom shares in Q1 2026, an estimated $705K.
  • DexCom made up 0.01% of Lido Advisors's portfolio in Q1 2026, its #691 holding.
  • Lido Advisors first reported a position in DexCom in Q4 2018 and has held it in 28 quarters since.
  • Lido Advisors's DexCom position peaked at $8.49M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.